SSRI Antidepressant Medications: Adverse Effects and Tolerability
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Side effects of antidepressants can be predicted by receptor selectivity and site of action. Although the selective serotonin reuptake inhibitors (SSRIs) have better overall safety and tolerability than older antidepressants, broad-based experience with SSRIs has shown the frequency and type of side effects to be increased relative to clinical trial data. The author explores the reasons for the different profiles and discusses adverse effects, especially sexual dysfunction, weight gain, and sleep disturbance, the most troubling adverse events seen during long-term SSRI therapy. The informed management of these side effects by primary care practitioners supports successful treatment of depression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It has been routinely identified to cause less severe withdrawal effects than other SSRIs, which has been attributed to its longer half-life 3,30,75 .”
From Tapering of SSRI treatment to mitigate withdrawal symptoms (2019) · cites this paper as [75]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However many of these drugs can acutely induce adverse side effects including anxiety and increased risk of suicidal behaviors (Ferguson, 2001; Gartlehner et al., 2011; Vaswani et al., 2003).”
From Molecular and anatomical organization of the dorsal raphe nucleus (2019) · cites this paper as Ferguson, 2001
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“During long-term use of SSRIs, the most troubling adverse effects seem to be gastrointestinal problems, sleep disturbances and sexual dysfunction,49”
From Should antidepressants be used for major depressive disorder? (2020) · cites this paper as [49]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“often intolerable side-effects”
From Psychedelics and Other Psychoplastogens for Treating Mental Illness. (2021) · cites this paper as [260]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“many patients refusing to take traditional antidepressants due to their side-effects”
From Psychedelics and Other Psychoplastogens for Treating Mental Illness. (2021) · cites this paper as [260]
Experimental — accuracy not yet measured
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Arky, R. A. (1994) · Cited by 2,632
The Arizona Sexual Experience Scale (ASEX): Reliability and Validity
A. McGahuey, A. J. G. (2000) · Journal of Sex & Marital Therapy · doi:10.1080/009262300278623 · Cited by 1,155
Effects of SSRIs on Sexual Function: A Critical Review
Rosen, R. C., Lane, R. M., & Menza, M. (1999) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199902000-00013 · Cited by 650
1995 Physicians' Desk Reference
Schild, S. M. (1995) · AORN Journal · doi:10.1016/s0001-2092(06)63819-2 · Cited by 497
Systematic Review and Guide to Selection of Selective Serotonin Reuptake Inhibitors
Edwards, J. G., & Anderson, I. (1999) · Drugs · doi:10.2165/00003495-199957040-00005 · Cited by 458
Mechanism of action of antidepressant medications.
Feighner, J. P. (1999) · PubMed · Cited by 323
Anderson, I. M. (1998) · Depression and Anxiety · doi:10.1002/(sici)1520-6394(1998)7:1+<1::aid-da1>3.3.co;2-j · Cited by 278
Anderson, I. M. (1998) · Depression and Anxiety · doi:10.1002/(sici)1520-6394(1998)7:1+<11::aid-da4>3.0.co;2-i · Cited by 266
Spigset, O. (1999) · Drug Safety · doi:10.2165/00002018-199920030-00007 · Cited by 225
Anorgasmia from Clomipramine in Obsessive-Compulsive Disorder: A Controlled Trial
Monteiro, W. O., Noshirvani, H. F., Marks, I. M., & Lelliott, P. T. (1987) · British Journal of Psychiatry · doi:10.1192/bjp.151.1.107 · Cited by 201
Cited by
Items 201–300 of 670
SSRIs and SNRIs: A review of the Discontinuation Syndrome in Children and Adolescents.
Hosenbocus, S., & Chahal, R. (2011) · PubMed Central · Cited by 52
Warden, D., Trivedi, M. H., Wisniewski, S. R., Kurian, B. T., Zisook, S., Kornstein, S. G., Friedman, E. S., Miyahara, S., Leuchter, A. F., D, M. F. M., et al. (2010) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181dbfd04 · Cited by 27
EEG in non-clinical drug safety assessments: Current and emerging considerations
Authier, S., Delatte, M. S., Kallman, M. J., Stevens, J., & Markgraf, C. G. (2016) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2016.03.002 · Cited by 27
Dogra, S., Kumar, A., Umrao, D., Sahasrabuddhe, A. A., & Yadav, P. N. (2016) · Scientific Reports · doi:10.1038/srep33401 · Cited by 27
Kendrick, T., Geraghty, A. W. A., Bowers, H., Stuart, B., Leydon, G., May, C., Yao, G., O’Brien, W., Glowacka, M., Holley, S., et al. (2020) · Trials · doi:10.1186/s13063-020-04338-7 · Cited by 26
Biomarkers of Stress in Music Interventions: A Systematic Review
Wong, M. M., Tahir, T., Wong, M., Baron, A., & Finnerty, R. (2021) · Journal of Music Therapy · doi:10.1093/jmt/thab003 · Cited by 37
Crawford, A. A., Lewis, G., Lewis, S. J., & Munafo, M. R. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.12.001 · Cited by 28
“SSRIinduced side effects may occur when levels of synaptic serotonin increase to an intolerably high concentration resulting in over-stimulation of serotonin receptors in the brain and periphery (Ferguson, 2001).”
BackgroundSymptom management challenges in heart failure: pharmacotherapy considerations
Stewart, D., & McPherson, M. L. (2017) · Heart Failure Reviews · doi:10.1007/s10741-017-9632-5 · Cited by 29
“prevalent with paroxetine than sertraline, while citalopram, citalopram, and fluoxetine are low risk [88, 89].”
BackgroundKutlu, M. G., Brady, L. J., Peck, E. G., Hofford, R. S., Yorgason, J. T., Siciliano, C. A., Kiraly, D. D., & Calipari, E. S. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.1116-18.2018 · Cited by 28
“However, directly targeting systems involved in reward learning and motivation often has a number of adverse side effects and these strategies have largely been ineffective for these symptom clusters (Ferguson, 2001).”
BackgroundWarren, M. (2007) · International journal of clinical practice · doi:10.1111/j.1742-1241.2007.01566.x · Cited by 29
Unexamined assumptions and unintended consequences of routine screening for depression
Cosgrove, L., Karter, J. M., Vaswani, A., & Thombs, B. D. (2018) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2018.03.007 · Cited by 26
Update on pharmacotherapy in psychodermatological disorders
Munoli, R. N., Shenoi, S. D., Soman, S., & Prabhu, S. S. (2020) · Indian Dermatology Online Journal · doi:10.4103/idoj.idoj_330_19 · Cited by 25
Makunts, T., Wollmer, M., & Abagyan, R. (2020) · Scientific Reports · doi:10.1038/s41598-020-69773-7 · Cited by 24
Meléndez, G. P. P., Valero-Jara, V., Acevedo-Hernández, P., & Thomas‐Valdés, S. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2122925 · Cited by 30
“However, the long-term drugs use can trigger adverse effects including weight gain, insomnia, gastrointestinal disturbances and sexual dysfunction (Ferguson 2001).”
BackgroundBoland, E. M., & Ross, R. J. M. (2015) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2015.07.005 · Cited by 25
“SSRIs and serotonin and norepinephrine reuptake inhibitors (SNRI) are frequently prescribed for the treatment of OCD; however, many of these drugs may have deleterious effects on sleep.(39) Given the relationship between obsessional thinking and sleep”
BackgroundThe Role of Therapeutic Drugs on Acquired Mitochondrial Toxicity
Morén, C., Juárez‐Flores, D. L., Cardellach, F., & Garrabou, G. (2016) · Current Drug Metabolism · doi:10.2174/1389200217666160322143631 · Cited by 25
Protective effects of melatonin on long-term administration of fluoxetine in rats
Khaksar, M., Oryan, A., Sayyari, M., Rezabakhsh, A., & Rahbarghazi, R. (2017) · Experimental and Toxicologic Pathology · doi:10.1016/j.etp.2017.05.002 · Cited by 29
Razack, S., Kandikattu, H. K., Venuprasad, M. P., Amruta, N., Khanum, F., Chuttani, K., & Mishra, A. K. (2018) · Metabolic Brain Disease · doi:10.1007/s11011-018-0261-z · Cited by 27
International and national quality and safety indicators for aged care
Caughey, G. E., Lang, C. E., Bray, S. C. E., Moldovan, M. V., Jorissen, R. N., Wesselingh, S. L., & Inacio, M. C. S. (2020) · Cited by 52
Grape‐derived polyphenols produce antidepressant effects via VGF‐ and BDNF‐dependent mechanisms
Jiang, C. S., Sakakibara, E., Lin, W., Wang, J., Pasinetti, G. M., & Salton, S. R. (2019) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14098 · Cited by 25
Chen, H., He, Q., Wang, M., Wang, X., Pu, C., Li, S., & Li, M. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.09.027 · Cited by 27
Leem, J., Cheong, M. J., Lee, H., Cho, E., Lee, S. Y., Kim, G.-W., & Kang, H. W. (2021) · Healthcare · doi:10.3390/healthcare9101351 · Cited by 23
“However, it is well known that long-term SSRI therapy is associated with several adverse events such as sexual dysfunction, sleep disturbance, and weight gain [9].”
BackgroundPrescribing selective serotonin reuptake inhibitors in older age
Topiwala, A., Chouliaras, L., & Ebmeier, K. P. (2013) · Maturitas · doi:10.1016/j.maturitas.2013.11.006 · Cited by 24
Are Selective Serotonin Reuptake Inhibitors Safe for Drivers? What is the Evidence?
Ravera, S., Ramaekers, J. G., den Berg, L. T. W. D. J., & de Gier, J. J. (2012) · Clinical Therapeutics · doi:10.1016/j.clinthera.2012.04.002 · Cited by 26
Merikanto, I., Partonen, T., Paunio, T., Castaneda, A. E., MARTTUNEN, M. J., & Urrila, A. S. (2017) · Chronobiology International · doi:10.1080/07420528.2017.1332072 · Cited by 27
“…including only patients without psychotropic treatments can present a selection bias, but then again psychotropic medication can affect the actualized sleep rhythm (Armitage et al., 1997; Ferguson, 2001; Golub & Hogrefe, 2016) and thus might skew the effect between depression and circadian rhythm.”
BackgroundBérard, A., Gaedigk, A., Sheehy, O., Chambers, C., Roth, M., Bozzo, P., Johnson, D., Kao, K. K., Lavigne, S. V., Wolfe, L., et al. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00402 · Cited by 25
“Increased plasma antidepressant concentration has been seen in slow metabolizers (Ververs et al., 2009), which would in turn lead to an increased frequency and severity of concentrationdependent adverse drug effects (Ferguson, 2001; Rau et al., 2004).”
BackgroundThe Effect of Citalopram on Genome-Wide DNA Methylation of Human Cells
Kanherkar, R. R., Getachew, B., Ben-Sheetrit, J., Varma, S. R., Heinbockel, T., Tizabi, Y., & Csoka, A. B. (2018) · International Journal of Genomics · doi:10.1155/2018/8929057 · Cited by 26
“While blocking reuptake of serotonin can increase its bioavailability and stimulate postsynaptic serotonin receptors to positively affect mood and anxiety, excessive firing of such serotoninregulated neurons can negatively affect sleep, appetite, sexual function, and pain sensation, raising concerns regarding their ad…”
BackgroundInfluentialOpioid signaling and design of analgesics
Paul, B., Sribhashyam, S., & Majumdar, S. (2022) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2022.06.017 · Cited by 49
Bipolar depression: a new role for atypical antipsychotics?
Keck, P. E. (2005) · Bipolar Disorders · doi:10.1111/j.1399-5618.2005.00213.x · Cited by 23
McIntyre, R. S. (2017) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s150589 · Cited by 25
“7 kg),(49) in contrast to mean weight gains seen in long-term studies of other SSRI drugs (up to ~10 kg).(50) Additionally, vilazodone had no significant placebo-subtracted effect on sexual functioning in patients with MDD(51) or in healthy adult volunteers,(52) which is an important factor to consider when treating p…”
Makunts, T., Cohen, I. V., Lee, K. C., & Abagyan, R. A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0195521 · Cited by 24
“Nearly half of the patients who take antidepressants discontinue therapy prematurely due to late onset of beneficial effects, adverse effects, and fear of dependence[3, 4].”
BackgroundNolan, T. L., Lapinsky, D. J., Talbot, J. N., Indarte, M., Liu, Y., Manepalli, S., Geffert, L. M., Amos, M. E., Taylor, P. N., Madura, J. D., et al. (2011) · ACS Chemical Neuroscience · doi:10.1021/cn200044x · Cited by 23
New design strategies for antidepressant drugs
Immadisetty, K., Geffert, L. M., Surratt, C. K., & Madura, J. D. (2013) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2013.830102 · Cited by 25
“The adverse effect may be severe enough to cause discontinuance of the SSRI [18].”
BackgroundCao, B., Park, C., Rosenblat, J. D., Chen, Y., Iacobucci, M., Subramaniapillai, M., Mansur, R. B., Zuckerman, H., Lee, Y. L., & McIntyre, R. S. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881119874485 · Cited by 23
Wang, S., Qi, L., Liu, H., Lei, K., Wang, X., & Liu, R. (2020) · RSC Advances · doi:10.1039/d0ra05886f · Cited by 22
Hicks, A. J., Clay, F. J., James, A. C., Hopwood, M., & Ponsford, J. L. (2022) · Neuropsychology Review · doi:10.1007/s11065-022-09543-6 · Cited by 26
“…be more burdensome for TBI survivors, due to the overlap in TBI related sequalae and common side effects of anti-depressants such as sleep problems and sexual dysfunction (Castriotta et al., 2007; Mathias & Alvaro, 2012; Hibbard et al., 2000; Ponsford, 2003; Downing et al., 2013; Ferguson, 2001).”
BackgroundOnline survey of medicinal cannabis users: Qualitative analysis of patient-level data
Garcia‐Romeu, A., Elmore, J. S., Mayhugh, R. E., Schlienz, N. J., Martin, E. L., Strickland, J. C., Bonn‐Miller, M. O., Jackson, H., & Vandrey, R. G. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.965535 · Cited by 32
“Furthermore, adverse side effects of antiepileptic (Perucca and Gilliam, 2012), antidepressant (Ferguson, 2001), and opioid medications are well-established (Benyamin et al., 2008).”
BackgroundShram, M. J., Henningfield, J. E., Apseloff, G., Gorodetzky, C. W., Martin, S. D., Vocci, F. L., Sapienza, F. L., Kosten, T. R., Huston, J., Buchhalter, A. R., et al. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02473-8 · Cited by 24
“In addition, serotonergic antidepressants have meaningful metabolic side effects, including weight gain, and cause sleep disruption and sexual dysfunction [4, 5].”
BackgroundJun, J. H., Choi, T., Lee, J. A., Yun, K., & Lee, M. S. (2014) · Maturitas · doi:10.1016/j.maturitas.2014.08.008 · Cited by 21
“[7] Ferguson JM.”
BackgroundPlant-derived medicines for neuropathies: a comprehensive review of clinical evidence
Ebrahimi, F., Farzaei, M. H., Bahramsoltani, R., Heydari, M., Naderinia, K., & Rahimi, R. (2019) · Reviews in the Neurosciences · doi:10.1515/revneuro-2018-0097 · Cited by 24
“, 2017) or in other chronic pain conditions, the long-term use of conventional analgesics such as opioids is sometimes accompanied by unpleasant adverse effects such as constipation or drowsiness (Ferguson, 2001).”
BackgroundWentink, C., Huijbers, M. J., Lucassen, P. L., van der Gouw, A., Kramers, C., Spijker, J., & Speckens, A. E. (2019) · British Journal of General Practice · doi:10.3399/bjgp19x706001 · Cited by 19
Analgesia for non-specific low back pain
Jones, C. M. P., Underwood, M., Chou, R., Schoene, M., Sabzwari, S., Cavanagh, J., & Lin, C.-W. C. (2024) · BMJ · doi:10.1136/bmj-2024-080064 · Cited by 21
“48”
Fibromyalgia Syndrome: A Case Report on Controlled Remission of Symptoms by a Dietary Strategy
Lattanzio, S. M., & Imbesi, F. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00094 · Cited by 27
Wang, J., Fernández, A. E., Tiano, S., Huang, J., Floyd, Z. E., Poulev, A., Ribnicky, D., & Pasinetti, G. M. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/7418681 · Cited by 23
“Approximately half of the patients, however, do not fully respond to the approved antidepressants [1], and these treatments are often associated with therapeutic time lag and a wide range of undesirable “adverse” events [2].”
BackgroundPrakash, S., Rathore, C., Rana, K., Dave, A., Joshi, H., & Patel, J. (2018) · Annals of Indian Academy of Neurology · doi:10.4103/aian.aian_344_18 · Cited by 21
“[17] In one patient, migraine headache got aggravated by amitriptyline and valproate.”
InfluentialAlbert, U., Lamba, P., & Stahl, S. M. (2021) · CNS Spectrums · doi:10.1017/s1092852921000304 · Cited by 19
Domingues, R. R., Fricke, H. P., Sheftel, C. M., Bell, A. M., Sartori, L. C., Manuel, R. S. J., Krajco, C. J., Wiltbank, M. C., & Hernandez, L. L. (2022) · Toxics · doi:10.3390/toxics10010011 · Cited by 23
Calabrò, M., Fabbri, C., Kasper, S., Zohar, J., Souery, D., Montgomery, S., Albani, D., Forloni, G., Ferentinos, P. P., Rujescu, D., et al. (2022) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2022.01.008 · Cited by 19
Pilc, A., Machaczka, A., Kawalec, P., Smith, J. L., & Witkin, J. M. (2022) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2022.2111415 · Cited by 21
Savigamin, C., Samuthpongtorn, C., Mahakit, N., Nopsopon, T., Heath, J., & Pongpirul, K. (2022) · Nutrients · doi:10.3390/nu14173661 · Cited by 24
“Several monoaminergic drugs have been investigated for use in stroke, including serotonergic and dopaminergic drugs [3], but these drugs may cause a variety of side effects, including sexual dysfunction, weight gain, insomnia, or somnolence in selective serotonin reuptake inhibitors (SSRIs), and gastrointestinal side…”
BackgroundGolder, S., Medaglio, D., O’Connor, K., Hennessy, S., Gross, R., & Gonzalez‐Hernandez, G. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.23746 · Cited by 28
Bendriss, G., MacDonald, R. S., & McVeigh, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241511978 · Cited by 54
“Additionally, there are side effects associated with the use of medication, such as gastrointestinal disturbances and sexual dysfunction, which can further impact treatment adherence and quality of life [18].”
BackgroundSubeesh, V., Singh, H., Maheswari, E., & Beulah, E. (2017) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2017.09.005 · Cited by 21
“Since, serotonin receptors in the brain control sleep, appetite, mood change, emotions, anger etc., enhanced activity of serotonin will result in insomnia, agitation and anger like other SSRIs, most often reported with sertraline and fluoxetine (Ferguson, 2001).”
BackgroundArch, J. J., & Stanton, A. L. (2019) · Supportive Care in Cancer · doi:10.1007/s00520-019-04677-5 · Cited by 23
Sharma, T., Guski, L. S., Freund, N., Meng, D. M., & Gøtzsche, P. C. (2019) · International Journal of Risk & Safety in Medicine · doi:10.3233/jrs-195041 · Cited by 24
“Another issue was that the use of minor tranquilizers was permitted in 71% of the trial protocols for insomnia, which is a known adverse effect of antidepressant drugs [22, 23].”
Rubrofusarin Attenuates Chronic Restraint Stress-Induced Depressive Symptoms
Yi, J. H., Jeon, J., Kwon, H., Cho, E., Yun, J., Lee, Y. C., Ryu, J. H., Park, S. J., Cho, J. H., & Kim, D. H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103454 · Cited by 18
Linka, T., Sartory, G., Gastpar, M., Scherbaum, N., & Müller, B. W. (2009) · Psychiatry Research · doi:10.1016/j.psychres.2008.06.009 · Cited by 21
“Insomnia has also been reported as a frequent side-effect in SSRI treatment of major depression (Ferguson, 2001).”
Krause, D., Folkerts, M., Karch, S., Keeser, D., Chrobok, A. I., Zaudig, M., Hegerl, U., Juckel, G., & Pogarell, O. M. (2016) · Frontiers in Psychology · doi:10.3389/fpsyg.2015.01993 · Cited by 25
“…article was submitted to Psychopathology, a section of the journal Frontiers in Psychology Received: 01 July 2015 Accepted: 14 December 2015 Published: 22 January 2016 Citation: Krause D, Folkerts M, Karch S, Keeser D, Chrobok AI, Zaudig M, Hegerl U, Juckel G and Pogarell O (2016)…”
Mehdipour, A., Abedi, P., Ansari, S., & Dastoorpoor, M. (2022) · Journal of Complementary and Integrative Medicine · doi:10.1515/jcim-2020-0245 · Cited by 20
Metabolic bioactivation of antidepressants: advance and underlying hepatotoxicity
Khalil, S. M., MacKenzie, K. R., Maletić‐Savatić, M., & Li, F. (2024) · Drug Metabolism Reviews · doi:10.1080/03602532.2024.2313967 · Cited by 20
“…replaced by tricyclic antidepressants (tcAs) and selective serotonin reuptake inhibitors (SSRis), which have better efficacy and fewer side effects (Ferguson 2001). currently, the MAOis isocarboxazid, phenelzine, selegiline and tranylcypromine are still used to treat depression in clinical…”
BackgroundAcupuncture and Moxibustion as an Evidence-based Therapy for Cancer
Cho, W. C. S. (2012) · Evidence-based anticancer complementary and alternative medicine · doi:10.1007/978-94-007-4833-0 · Cited by 20
The effects of ketamine on sexual behavior, anxiety, and locomotion in female rats
Guarraci, F. A., Gonzalez, C. M. F., Lucero, D., Womble, P. D., Abdel‐Rahim, H., DeVore, J. E., Kunkel, M. N., Quadlander-Goff, E., Stinnett, M., & Boyette-Davis, J. A. (2017) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2017.12.004 · Cited by 22
“Unfortunately, the most effective medicinal treatment for depression, SSRIs (Ferguson, 2001), can cause nervousness, agitation, and other symptoms of anxiety (Gollan et al.”
BackgroundToxicity of Bupropion Overdose Compared With Selective Serotonin Reuptake Inhibitors
Overberg, A., Morton, S., Wagner, E., & Froberg, B. A. (2019) · PEDIATRICS · doi:10.1542/peds.2018-3295 · Cited by 24
“For instance, paroxetine is the most anticholinergic, whereas citalopram and escitalopram are most likely to cause QT prolongation.(27,28) Vilazodone and vortioxetine are new members of the SSRI class that received FDA approval for use in adults with depression in 2011 and 2013, respectively; they are not approved for…”
BackgroundTakemoto, E. E., Oss, K. R. V., Chamany, S., Brite, J., & Brackbill, R. M. (2020) · Psychological Medicine · doi:10.1017/s0033291720001208 · Cited by 20
“Further, treatment with selective serotonin reuptake inhibitors (SSRIs) and other psychotropic medications can lead to weight gain (Fava, 2000; Ferguson, 2001; Vieweg et al., 2008).”
BackgroundPatterns of Antidepressant Use in Italy: Therapy Duration, Adherence and Switching
Esposti, L. D., Piccinni, C. P., Sangiorgi, D., Fagiolini, A. M., & Buda, S. (2015) · Clinical Drug Investigation · doi:10.1007/s40261-015-0332-4 · Cited by 19
“gastrointestinal disturbances, sexual dysfunctions, weight gain, effect on sleep [23]), which could scarcely be tolerated by some patients.”
BackgroundSchlicker, S., Weisel, K. K., Buntrock, C., Berking, M., Nobis, S., Lehr, D., Baumeister, H., Snoek, F. J., Riper, H. M., & Ebert, D. D. (2019) · Journal of Diabetes Research · doi:10.1155/2019/2634094 · Cited by 20
Ginsberg, L. D. (2009) · CNS Spectrums · doi:10.1017/s1092852900026353 · Cited by 19
Blazie, S. M., & Jin, Y. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00509 · Cited by 21
Jang, D., Lee, H.-J., Lee, K., Kim, K.-R., Won, R., Lee, S. E., & Shim, I. (2019) · BioMed Research International · doi:10.1155/2019/5705232 · Cited by 20
“effects such as nausea, akathisia, sexual dysfunction, and sleep disturbance [22, 23].”
BackgroundMcCarthy, B., O’Neill, G. J., & Abu‐Ghannam, N. (2022) · Marine Drugs · doi:10.3390/md20080493 · Cited by 20
New investigational agents for the treatment of major depressive disorder
Pochwat, B., Krupa, A. J., Siwek, M., & Szewczyk, B. (2022) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2022.2113376 · Cited by 23
“effects that are sometimes very bothersome and difficult to deal with [5].”
BackgroundVasiliu, O. (2023) · Pharmaceuticals · doi:10.3390/ph16030411 · Cited by 22
Fotio, Y., Tagne, A. M., Jung, K., & Piomelli, D. (2023) · Psychopharmacology · doi:10.1007/s00213-023-06358-y · Cited by 19
“Along with their modest efficacy, these approaches are limited by limited tolerability, persistence of subthreshold symptoms, and in the case of SSRIs, multiple side effects (Cukor et al. 2010; Ferguson 2001; Hoskins et al. 2015; Schnurr et al. 2007).”
Perineuronal Nets Alterations Contribute to Stress-Induced Anxiety-Like Behavior
Li, X., Ren, D., Luo, B., Liu, Z., Li, N.-Y., Zhou, T. G., & Fei, E. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03596-1 · Cited by 21
“FXT, a selective serotonin reuptake inhibitor (SSRI) and a second-generation antidepressant, has been extensively administered to patients suffering from depression and anxiety since the 1990s [49, 50].”
Hashemi-Mohammadabad, N., Taghavi, S.-A., Lambert, N., Moshtaghi, R., Bazarganipour, F., & Sharifi, M. (2024) · BMC Psychiatry · doi:10.1186/s12888-023-05429-w · Cited by 23
The multifaceted effects of fluoxetine treatment on cognitive functions
Ampuero, E., Luarte, A., Flores, F. S., Soto, A. I., Pino, C. H., Silva, V., Erlandsen, M., Concha, T., & Wyneken, Ú. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1412420 · Cited by 26
“…non-gastrointestinal side effects have been documented, such as headache, dizziness, variations in sleep patterns, anxiety, tremor, and sexual dysfunction, painting a comprehensive picture of the drug ’ s tolerability (Ben fi eld et al., 1986; Ferguson, 2001; Carr and Ensom, 2002; Wernicke, 2004).”
BackgroundSonawane, R., Deore, V., Patil, S. D., Patil, C. R., Surana, S. J., & Goyal, R. K. (2015) · Physiology & Behavior · doi:10.1016/j.physbeh.2015.02.036 · Cited by 19
Borgers, A. J., Koopman, K. E., Bisschop, P. H. L. T., Serlie, M. J. M., Swaab, D. F., Fliers, E., la Fleur, S. E., & Alkemade, A. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00106 · Cited by 25
“Side-effects of specific serotonin reuptake inhibitors include increased appetite and increased body weight (Fava, 2000; Ferguson, 2001; Raeder et al., 2006).”
Redox metabolism modulation as a mechanism in SSRI toxicity and pharmacological effects
Ștefan, M.-G., Kiss, B., Gutleb, A. C., & Loghin, F. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02721-6 · Cited by 22
“It is believed that a major role in the occurrence of such sexual dysfunctions is played by SSRIs decreasing NO levels (Ferguson 2001).”
BackgroundRepurposing Zileuton as a Depression Drug Using an AI and In Vitro Approach
Kubick, N., Pajares, M., Enache, I., Manda, G., & Mickael, M. (2020) · Molecules · doi:10.3390/molecules25092155 · Cited by 18
“SSRI and SNRI side effects include sexual dysfunction, weight gain, and sleep disturbance [17].”
BackgroundMilosavljevic, J. Z., Milosavljević, M. N., Arsenijević, P. S., Milentijević, M. N., & Stefanović, S. (2021) · International Journal of Psychiatry in Clinical Practice · doi:10.1080/13651501.2021.1872647 · Cited by 23
Hoshina, N., Johnson-Venkatesh, E. M., Rally, V. R., Sant, J., Hoshina, M., Seiglie, M. P., & Umemori, H. (2022) · Journal of Neuroscience · doi:10.1523/jneurosci.1843-21.2022 · Cited by 23
Potential Utility of Cannabidiol in Stress-Related Disorders
Lookfong, N. A., Raup‐Konsavage, W. M., & Silberman, Y. (2022) · Cannabis and Cannabinoid Research · doi:10.1089/can.2022.0130 · Cited by 20
Cortisol as a Target for Treating Mental Disorders: A Promising Avenue for Therapy
Patel, V. K., Vaishnaw, A., Shirbhate, E., Kore, R., Singh, V. P., Veerasamy, R., & Rajak, H. (2023) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/0113895575262104230928042150 · Cited by 20
Velasquez, D., Quines, C. B., Pistoia, R. P., Zeni, G. R., & Nogueira, C. W. (2016) · Physiology & Behavior · doi:10.1016/j.physbeh.2016.12.024 · Cited by 18
Antidepressants and Antipsychotic Agents as Repurposable Oncological Drug Candidates
Antoszczak, M., Markowska, A., Markowska, J., & Huczyński, A. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327666200907141452 · Cited by 21
Taylor, G. V., Paladines, R., Marti, A., Jacobs, D., Tint, S., Fones, A., Hamilton, H., Yu, L., Amini, S., & Hettinger, J. D. (2021) · Electrochimica Acta · doi:10.1016/j.electacta.2021.139118 · Cited by 18
Romero‐Martínez, Á., Bressanutti, S., & Moya‐Albiol, L. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9030882 · Cited by 19
Naß, J., Kampf, C. J., & Efferth, T. (2021) · Molecules · doi:10.3390/molecules26071827 · Cited by 19
“Although there are some drugs for anti-depressive treatment, their success rate is limited, partly because of severe side effects [25].”
BackgroundLeeuwen, E. V., Anthierens, S., van Driel, M., Sutter, A. D., Beir, R. D., & Christiaens, T. (2022) · Acta Clinica Belgica · doi:10.1080/17843286.2021.2024384 · Cited by 21
Remus: System for remote deep brain interventions
Webb, T. D., Wilson, M. G., Odéen, H., & Kubanek, J. (2022) · iScience · doi:10.1016/j.isci.2022.105251 · Cited by 16
Coriandrum sativum and Its Utility in Psychiatric Disorders
Santibáñez, A., Jiménez‐Ferrer, E., Angulo‐Bejarano, P. I., Sharma, A. K., & Herrera-Ruiz, M. L. (2023) · Molecules · doi:10.3390/molecules28145314 · Cited by 17
“The adverse effects described for this group are nervousness, nausea, restlessness, headache, fatigue, increased or decreased appetite, weight gain, weight loss, tremors, sweating, prolongation of the QTc wave in the electrocardiogram, sexual dysfunction, diarrhea, constipation [60,61].”
BackgroundCould the underestimation of bipolarity obstruct the search for novel antidepressant drugs?
Fornaro, M., Aguglia, E., Dell’Osso, L., & Perugi, G. (2011) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2011.632366 · Cited by 17
“The efficacy and tolerability of the SSRIs -- which are still the most commonly prescribed antidepressant drugs [15] and were introduced as a better tolerated, yet effective, alternative to the TCAs -- have been questioned, especially for the most severe cases of depression [44].”
BackgroundInsomnia management in prisons in England and Wales: a mixed‐methods study
Dewa, L. H., Hassan, L., Shaw, J. J., & Senior, J. (2017) · Journal of Sleep Research · doi:10.1111/jsr.12503 · Cited by 19
“…insomnia include female sex (Zhang and Wing, 2006), stressful life events (Drake et al., 2014), comorbid mental and physical disorders (Abad and Guilleminault, 2005; Czeisler, 2015) and, to a lesser extent, substance misuse (Mahfoud et al., 2009) and prescription medication use (Ferguson, 2001).”
BackgroundHasbal‐Celikok, G., Kara, M., Sánchez, M., Owsianik, C., Gómez-Serranillos, M. P., Yilmaz‐Ozden, T., Öztaş, E., Zengin, Ö. S., Özhan, G., Arda, N., et al. (2024) · Nutrients · doi:10.3390/nu16203459 · Cited by 16
“Conventional treatments, including antidepressant medications and cognitive enhancers, often come with limitations such as adverse side effects, the development of tolerance, delayed onset of therapeutic effects, and inconsistent efficacy [17–19].”
BackgroundGeneral practitioners’ perspectives on discontinuation of long-term antidepressants in nursing homes
Leeuwen, E. V., Anthierens, S., van Driel, M., Sutter, A. I. M. D., van den Branden, E., & Christiaens, T. (2022) · European Journal of General Practice · doi:10.1080/13814788.2022.2038131 · Cited by 18
“AD is associated with a range of adverse events such as sleep disturbance, weight gain, and gastrointestinal problems [8], alongside feeling emotionally numb and becoming physically dependent [9,10].”
BackgroundNatural Products for the Treatment of Post-stroke Depression
Fang, C., Zhang, Z., Xu, H., Liu, Y., Wang, X., Ling, Y., Xu, Y., Zhu, Z., Zhang, A., Shao, A., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.918531 · Cited by 23
Clinical pharmacological innovation in the treatment of depression
Witkin, J. M., Golani, L. K., & Smith, J. L. (2023) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2023.2198703 · Cited by 17
Eadon, M. T., Rosenman, M. B., Zhang, P., Fulton, C. R., Callaghan, J. T., Holmes, A. M., Levy, K. D., Gupta, S. K., Haas, D. M., Vuppalanchi, R., et al. (2023) · The Pharmacogenomics Journal · doi:10.1038/s41397-023-00315-w · Cited by 19
Henriksen, K. N., Spigset, O., Brandlistuen, R. E., Ystrøm, E., Koren, G., & Nordeng, H. (2016) · International Journal of Epidemiology · doi:10.1093/ije/dyw049 · Cited by 18
Metadata
- Authors
- Ferguson, J. M.
- Affiliations
- University of Utah (US)
- Corresponding author
- Ferguson, James M.
- ORCID
- Ferguson, James M.
- Venue
- The Primary Care Companion For CNS Disorders
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2001-02-01
- Volume
- 3
- Issue
- 1
- Pages
- 22-27
- ISSN
- 2155-7772 (ISSN-L)
- 2155-7780
- PMC
- PMC181155
- OpenAlex
- W2024985387
- Cited by
- 669
- References
- 23
- Citations by year
- 2026: 26 · 2025: 35 · 2024: 33 · 2023: 46 · 2022: 63 · 2021: 69 · 2020: 56 · 2019: 64 · 2018: 45 · 2017: 47 · 2016: 36 · 2015: 28 · 2014: 27 · 2013: 24 · 2012: 11
- FWCI
- 0.89
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Primary Care Companion For CNS Disorders (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Social Sciences › Psychology › Clinical Psychology › Psychological Treatments and Disorders
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- selective serotonin reuptake inhibitors, antidepressant side effects, sexual dysfunction, weight gain, sleep disorders, depression treatment, primary care management
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.